{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/IMNM/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-09T09:54:29.382Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":3648,"canonical_name":"Immunome Inc.","cik":"0001472012","uei":null,"lei":null,"duns":null,"ticker":"IMNM"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":59},"count":59,"timeline":[{"ts":"2026-09-11","kind":"sec.form144","reporter":"Higgins Jack","title":"Officer","shares":13200,"usd_value":334224,"security_title":"Common","approx_sale_date":"2026-09-11","accession_number":"0001959173-26-006875","importance":40.0668448},{"ts":"2026-09-11","kind":"sec.filing","form_type":"144","title":"144 — Immunome Inc. — 2026-09-11","url_slug":"/sec/cik-0001472012/144/0001959173-26-006875","accession_number":"0001959173-26-006875","importance":30},{"ts":"2026-08-11","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Immunome Inc. — 2026-08-11","url_slug":"/sec/cik-0001472012/10-q/0001193125-26-344636","accession_number":"0001193125-26-344636","importance":45},{"ts":"2026-08-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Immunome Inc. — 2026-08-11","url_slug":"/sec/cik-0001472012/8-k/0001193125-26-344577","accession_number":"0001193125-26-344577","importance":35},{"ts":"2026-08-11","kind":"sec.filing","form_type":"S-8","title":"S-8 — Immunome Inc. — 2026-08-11","url_slug":"/sec/cik-0001472012/s-8/0001193125-26-344743","accession_number":"0001193125-26-344743","importance":30},{"ts":"2026-07-09","kind":"sec.filing","form_type":"4","title":"4 — Immunome Inc. — 2026-07-09","url_slug":"/sec/cik-0001472012/4/0001831215-26-000002","accession_number":"0001831215-26-000002","importance":30},{"ts":"2026-07-07","kind":"sec.form144","reporter":"Horn Kinney","title":"Officer","shares":1092,"usd_value":27300,"security_title":"Common","approx_sale_date":"2026-07-07","accession_number":"0001959173-26-005148","importance":40.00546},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Barchas Isaac","title":"","shares":16906,"price_per_share":24.2,"usd_value":409125,"security_title":"Common Stock","importance":35.4091252},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Horn Kinney","title":"CHIEF BUSINESS OFFICER","shares":1092,"price_per_share":25,"usd_value":27300,"security_title":"Common Stock","importance":35.0273},{"ts":"2026-07-07","kind":"sec.filing","form_type":"144","title":"144 — Immunome Inc. — 2026-07-07","url_slug":"/sec/cik-0001472012/144/0001959173-26-005148","accession_number":"0001959173-26-005148","importance":30},{"ts":"2026-07-07","kind":"sec.filing","form_type":"4","title":"4 — Immunome Inc. — 2026-07-07","url_slug":"/sec/cik-0001472012/4/0001808343-26-000007","accession_number":"0001808343-26-000007","importance":30},{"ts":"2026-07-07","kind":"sec.filing","form_type":"4","title":"4 — Immunome Inc. — 2026-07-07","url_slug":"/sec/cik-0001472012/4/0001997584-26-000004","accession_number":"0001997584-26-000004","importance":30},{"ts":"2026-07-07","kind":"sec.insider.m","reporter":"Horn Kinney","title":"CHIEF BUSINESS OFFICER","shares":1092,"price_per_share":12.92,"usd_value":14109,"security_title":"Common Stock","importance":15.01410864},{"ts":"2026-07-06","kind":"sec.form144","reporter":"ABHMC II, LLC","title":"Shareholder","shares":100000,"usd_value":2361000,"security_title":"Common","approx_sale_date":"2026-07-06","accession_number":"0001628280-26-047387","importance":40.4722},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Barchas Isaac","title":"","shares":83094,"price_per_share":24.11,"usd_value":2003396,"security_title":"Common Stock","importance":37.00339634},{"ts":"2026-07-06","kind":"sec.filing","form_type":"144","title":"144 — Immunome Inc. — 2026-07-06","url_slug":"/sec/cik-0001472012/144/0001628280-26-047387","accession_number":"0001628280-26-047387","importance":30},{"ts":"2026-07-02","kind":"sec.form144","reporter":"ABHMC II, LLC","title":"Shareholder","shares":100000,"usd_value":2149000,"security_title":"Common","approx_sale_date":"2026-07-02","accession_number":"0001628280-26-046982","importance":40.4298},{"ts":"2026-07-02","kind":"sec.form144","reporter":"Lechleider Robert","title":"Officer","shares":55000,"usd_value":1188000,"security_title":"Common","approx_sale_date":"2026-07-02","accession_number":"0001959173-26-005049","importance":40.2376},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"Barchas Isaac","title":"","shares":75665,"price_per_share":22.35,"usd_value":1691113,"security_title":"Common Stock","importance":36.69111275},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"Barchas Isaac","title":"","shares":24335,"price_per_share":23.33,"usd_value":567736,"security_title":"Common Stock","importance":35.56773555},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"Lechleider Robert","title":"Chief Medical Officer","shares":22714,"price_per_share":21.95,"usd_value":498572,"security_title":"Common Stock","importance":35.4985723},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"Lechleider Robert","title":"Chief Medical Officer","shares":16072,"price_per_share":23.44,"usd_value":376728,"security_title":"Common Stock","importance":35.37672768},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"Lechleider Robert","title":"Chief Medical Officer","shares":16214,"price_per_share":22.76,"usd_value":369031,"security_title":"Common Stock","importance":35.36903064},{"ts":"2026-07-02","kind":"sec.filing","form_type":"144","title":"144 — Immunome Inc. — 2026-07-02","url_slug":"/sec/cik-0001472012/144/0001628280-26-046982","accession_number":"0001628280-26-046982","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"144","title":"144 — Immunome Inc. — 2026-07-02","url_slug":"/sec/cik-0001472012/144/0001959173-26-005049","accession_number":"0001959173-26-005049","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — Immunome Inc. — 2026-07-02","url_slug":"/sec/cik-0001472012/4/0001808343-26-000005","accession_number":"0001808343-26-000005","importance":30},{"ts":"2026-07-02","kind":"sec.insider.m","reporter":"Lechleider Robert","title":"Chief Medical Officer","shares":55000,"price_per_share":8.73,"usd_value":480150,"security_title":"Common Stock","importance":15.48015},{"ts":"2026-06-30","kind":"sec.form144","reporter":"ABHMC II, LLC","title":"Shareholder","shares":100000,"usd_value":2104000,"security_title":"Common","approx_sale_date":"2026-06-30","accession_number":"0001628280-26-046298","importance":40.4208},{"ts":"2026-06-30","kind":"sec.form144","reporter":"Arsenal Bridge Venture II-B, LLC","title":"Shareholder","shares":1050,"usd_value":22092,"security_title":"Common","approx_sale_date":"2026-06-30","accession_number":"0001628280-26-046297","importance":40.0044184},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Barchas Isaac","title":"","shares":101050,"price_per_share":21.12,"usd_value":2134176,"security_title":"Common Stock","importance":37.134176},{"ts":"2026-06-30","kind":"sec.filing","form_type":"144","title":"144 — Immunome Inc. — 2026-06-30","url_slug":"/sec/cik-0001472012/144/0001628280-26-046297","accession_number":"0001628280-26-046297","importance":30},{"ts":"2026-06-30","kind":"sec.filing","form_type":"144","title":"144 — Immunome Inc. — 2026-06-30","url_slug":"/sec/cik-0001472012/144/0001628280-26-046298","accession_number":"0001628280-26-046298","importance":30},{"ts":"2026-06-29","kind":"sec.filing","form_type":"4","title":"4 — Immunome Inc. — 2026-06-29","url_slug":"/sec/cik-0001472012/4/0001997584-26-000002","accession_number":"0001997584-26-000002","importance":30},{"ts":"2026-06-25","kind":"sec.form144","reporter":"Lechleider Robert","title":"Officer","shares":55000,"usd_value":1085150,"security_title":"Common","approx_sale_date":"2026-06-25","accession_number":"0001959173-26-004870","importance":40.21703},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Lechleider Robert","title":"Chief Medical Officer","shares":40580,"price_per_share":19.56,"usd_value":793745,"security_title":"Common Stock","importance":35.7937448},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Lechleider Robert","title":"Chief Medical Officer","shares":14420,"price_per_share":20.66,"usd_value":297917,"security_title":"Common Stock","importance":35.2979172},{"ts":"2026-06-25","kind":"sec.filing","form_type":"144","title":"144 — Immunome Inc. — 2026-06-25","url_slug":"/sec/cik-0001472012/144/0001959173-26-004870","accession_number":"0001959173-26-004870","importance":30},{"ts":"2026-06-25","kind":"sec.insider.m","reporter":"Lechleider Robert","title":"Chief Medical Officer","shares":55000,"price_per_share":8.73,"usd_value":480150,"security_title":"Common Stock","importance":15.48015},{"ts":"2026-06-17","kind":"sec.filing","form_type":"4","title":"4 — Immunome Inc. — 2026-06-17","url_slug":"/sec/cik-0001472012/4/0001994071-26-000004","accession_number":"0001994071-26-000004","importance":30},{"ts":"2026-06-15","kind":"sec.form144","reporter":"Rosett Max","title":"Officer","shares":60000,"usd_value":1117800,"security_title":"Common","approx_sale_date":"2026-06-15","accession_number":"0001959173-26-004650","importance":40.22356},{"ts":"2026-06-15","kind":"sec.insider.s","reporter":"Rosett Max","title":"Chief Financial Officer","shares":60000,"price_per_share":18.23,"usd_value":1093800,"security_title":"Common Stock","importance":36.0938},{"ts":"2026-06-15","kind":"sec.filing","form_type":"144","title":"144 — Immunome Inc. — 2026-06-15","url_slug":"/sec/cik-0001472012/144/0001959173-26-004650","accession_number":"0001959173-26-004650","importance":30},{"ts":"2026-06-15","kind":"sec.insider.m","reporter":"Rosett Max","title":"Chief Financial Officer","shares":60000,"price_per_share":1.05,"usd_value":63000,"security_title":"Common Stock","importance":15.063},{"ts":"2026-06-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Immunome Inc. — 2026-06-12","url_slug":"/sec/cik-0001472012/8-k/0001193125-26-269383","accession_number":"0001193125-26-269383","importance":35},{"ts":"2026-06-12","kind":"sec.filing","form_type":"4","title":"4 — Immunome Inc. — 2026-06-12","url_slug":"/sec/cik-0001472012/4/0001808343-26-000002","accession_number":"0001808343-26-000002","importance":30},{"ts":"2026-06-12","kind":"sec.filing","form_type":"4","title":"4 — Immunome Inc. — 2026-06-12","url_slug":"/sec/cik-0001472012/4/0001908755-26-000001","accession_number":"0001908755-26-000001","importance":30},{"ts":"2026-06-12","kind":"sec.filing","form_type":"4","title":"4 — Immunome Inc. — 2026-06-12","url_slug":"/sec/cik-0001472012/4/0001953094-26-000002","accession_number":"0001953094-26-000002","importance":30},{"ts":"2026-06-05","kind":"sec.insider.p","reporter":"BIENAIME JEAN JACQUES","title":"","shares":6000,"price_per_share":19.48,"usd_value":116880,"security_title":"Common Stock","importance":50.11688},{"ts":"2026-06-05","kind":"sec.insider.p","reporter":"BIENAIME JEAN JACQUES","title":"","shares":3500,"price_per_share":19.46,"usd_value":68110,"security_title":"Common Stock","importance":50.06811},{"ts":"2026-06-05","kind":"sec.insider.p","reporter":"BIENAIME JEAN JACQUES","title":"","shares":1000,"price_per_share":19.27,"usd_value":19270,"security_title":"Common Stock","importance":50.01927},{"ts":"2026-06-05","kind":"sec.insider.s","reporter":"BIENAIME JEAN JACQUES","title":"","shares":10000,"price_per_share":19.41,"usd_value":194100,"security_title":"Common Stock","importance":35.1941},{"ts":"2026-06-05","kind":"sec.insider.s","reporter":"BIENAIME JEAN JACQUES","title":"","shares":500,"price_per_share":19.44,"usd_value":9720,"security_title":"Common Stock","importance":35.00972},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Immunome Inc. — 2026-05-15","url_slug":"/sec/cik-0001472012/schedule-13g/0000919574-26-003222","accession_number":"0000919574-26-003222","importance":55},{"ts":"2026-05-15","kind":"sec.insider.p","reporter":"BIENAIME JEAN JACQUES","title":"","shares":5000,"price_per_share":20.7,"usd_value":103500,"security_title":"Common Stock","importance":50.1035},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Redmile Group, LLC — 2026-05-15","url_slug":"/sec/cik-0001425738/schedule-13g-a/0001104659-26-062570","accession_number":"0001104659-26-062570","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Immunome Inc. — 2026-05-15","url_slug":"/sec/cik-0001472012/schedule-13g-a/0000919574-26-003480","accession_number":"0000919574-26-003480","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Immunome Inc. — 2026-05-15","url_slug":"/sec/cik-0001472012/schedule-13g-a/0001897612-26-000495","accession_number":"0001897612-26-000495","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Immunome Inc. — 2026-05-12","url_slug":"/sec/cik-0001472012/10-q/0001193125-26-219425","accession_number":"0001193125-26-219425","importance":45},{"ts":"2026-05-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Immunome Inc. — 2026-05-12","url_slug":"/sec/cik-0001472012/8-k/0001193125-26-219367","accession_number":"0001193125-26-219367","importance":35}]}